GLP-1s have taken the country by storm. Patients are losing and keeping off weight at levels previously only seen through bariatric surgery. Research trials have shown the drugs to be effective at reducing the risk of heart attack, stroke, and cardiovascular death. They protect the kidneys, reduce sleep apnea, and treat fatty liver and peripheral artery disease – all while being studied for a laundry-list of additional indications. The drugs originally designed for glucose control in diabetes...